Answers are grounded in this paper and cite their sources.
We found that three tumor patients treated with mouse mAbs have T cells that recognize processed mouse Ig on autologous APC in a class II-restricted fashion, and we have shown that mouse mAbs directed against various cell surface molecules can be used as antigens to focus these T cells on an MHC class II-positive target of choice.
No takes yet. Share an insight, caveat, or question.
Lanzavecchia et al. (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: